HCC1143（人乳腺癌细胞）
CBP60368
询 价
索取STR
产品描述
产品数据库
| I. General information | |
| Synonyms: | HCC1143 |
| Background: | HCC1143 is a poorly differentiated cell line that was initiated on August 30, 1994; it took 29 months to establish. HCC1143 was derived from an invasive ductal carcinoma with no lymph node metastases. |
| Species: | Homo sapiens, human |
| Tissue: | breast; mammary gland/duct |
| Disease: | TNM stage IIA, grade 3, primary ductal carcinoma |
| Gender: | female, 52 years adult, Caucasian |
| Morphology: | epithelial |
| Growth Mode: | adherent |
| DNA Profile: | Amelogenin: X CSF1PO: 10 D13S317: 12 D16S539: 11,13 D5S818: 11 D7S820: 12 THO1: 9.3 TPOX: 12 vWA: 16 Our Cell Line Authentication Service |
| Culture Medium: |
RPMI-1640+10%FBS HCC1143完全培养基，#CBP60368M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Oncogene: | her2/neu -; p53 + |
| Genes Expressed: | Epithelial glycoprotein 2 [EGP2]; cytokeratin 19 |
| Cellular Products: | Epithelial glycoprotein 2 [EGP2]; cytokeratin 19 |
| Comments: | HCC1143 was derived from an invasive ductal carcinoma with no lymph node metastases. The cells are negative for expression of Her2-neu but positive for expression of p53. HCC1143 is positive for the epithelial cell specific marker Epithelial Glycoprotein 2 and for cytokeratin 19, and is negative for expression of estrogen receptor (ER) and progesterone receptor (PR). For more information, please contact us (4008-750-250). |
